Alzheimer Society of Canada
6 FOLLOWERS
Here you can find all the latest news and stories about Alzheimer's disease, dementia, and the brain. The Alzheimer Society of Canada is the leading nationwide health charity supporting people living with all forms of dementia, including Alzheimer's disease, as well as their caregivers and their families.
Alzheimer Society of Canada
3M ago
On July 6, 2023, the United States Food and Drug Administration granted full approval to the drug lecanemab (brand name Leqembi). This drug aims to slow the progress of Alzheimer's disease. Health Canada began to review the drug in May 2023 ..read more
Alzheimer Society of Canada
3M ago
In Canada, we are in danger of failing the rapidly growing number of people living with dementia and their care partners if services and supports are not tailored to their unique needs, according to a new study released today by the Alzheimer Society of Canada ..read more
Alzheimer Society of Canada
5M ago
When you participate in the IG Wealth Management Walk for Alzheimer's, you join thousands of Canadians who want to see a world without Alzheimer’s disease and other dementias ..read more
Alzheimer Society of Canada
5M ago
Alzheimer Society of Canada and Brain Canada Foundation Announce KTE Accelerator Grant Recipients ..read more
Alzheimer Society of Canada
8M ago
A program that claims to reverse Alzheimer’s disease is growing in popularity, despite lack of evidence that it works. Learn more about the Bredesen protocol and its claims ..read more
Alzheimer Society of Canada
9M ago
On July 17, 2023, American drug company Eli Lilly and Company released full results from a Phase 3 trial of donanemab, a drug that aims to target Alzheimer’s disease. Here’s what people in Canada might want to know about it ..read more
Alzheimer Society of Canada
9M ago
On July 6, 2023, the United States Food and Drug Administration granted full approval to the drug lecanemab (brand name Leqembi). This drug aims to slow the progress of Alzheimer's disease. Health Canada began to review the drug in May 2023 ..read more
Alzheimer Society of Canada
11M ago
On May 3, 2023, American drug company Eli Lilly and Company released some results from a Phase 3 trial of donanemab, a drug that aims to target Alzheimer’s disease. Here’s what people in Canada might want to know about it ..read more
Alzheimer Society of Canada
11M ago
Christopher Barry will join the Society on June 1, 2023 as CEO ..read more
Alzheimer Society of Canada
11M ago
Is the dementia information you’re reading trustworthy? These 5 tips will help you decide ..read more